Radiometer America has obtained the US Food and Drug Administration (FDA) 510(k) clearance for its cassette-based analyzer, ABL90 FLEX, an addition to the company’s blood gas line portfolio, which offers speed and high-throughput in a compact instrument.
The ABL90 FLEX, designed specifically for point-of-care (POC) testing, is a test-select analyzer that measures 16 parameters, including blood gases, electrolytes, metabolites and CO-oximetry, from just 65µl of whole blood.
Radiometer claimed that the ABL90 FLEX analyzer delivers results in 35 seconds, a turnaround time (TAT) unmatched by other blood gas analyzers on just 65µl of whole blood and also processes up to 44 samples per hour.
Radiometer said that the short TAT and high-throughput capacity, combined with the analyzer’s time and labor saving features, enable clinical caregivers to spend less time on testing and more on patient care.
The ABL90 FLEX, equally well-suited to lab or POC applications, offers automatic quality management (AQM) and easy replacement of consumables and fits easily within the hospital’s clinical POC areas.